Literature DB >> 6413412

Comparison of the properties of antirickettsial activity and interferon in mouse lymphokines.

J Turco, H H Winkler.   

Abstract

Certain properties of the antirickettsial activity and interferon in lymphokine preparations obtained from concanavalin A-stimulated mouse spleen cells were compared. Both the antirickettsial activity and interferon were relatively stable to heating at 56 degrees C, whereas both activities were destroyed by trypsin, by heating at 80 degrees C, or by exposure to pH 2 for 24 h. Both activities were likewise inhibited after incubation with rabbit antisera to partially purified murine interferon-gamma. In contrast to the mouse lymphokine preparations, which contained both interferon-gamma and antirickettsial activity, a preparation of virus-induced interferons (type I) had no detectable antirickettsial activity. Human foreskin fibroblasts, which were not sensitive to the antirickettsial activity in mouse lymphokines, acquired the ability to inhibit rickettsial growth when they were cocultured with sensitive mouse L929 cells treated with mouse lymphokines. These results are consistent with the idea that the antirickettsial activity in mouse lymphokines is due to interferon-gamma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413412      PMCID: PMC264519          DOI: 10.1128/iai.42.1.27-32.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Rickettsial hemolysis: rapid method for enumeration of metabolically active typhus rickettsiae.

Authors:  T S Walker; H H Winkler
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

2.  Interferon-induced transfer of viral resistance between animal cells.

Authors:  J E Blalock; S Baron
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

3.  Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  J S Youngner; S B Salvin
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

4.  Production of high-titered interferon in cultures of human diploid cells.

Authors:  E A Havell; J Vilcek
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

5.  In vitro studies of the action of antibiotics on Rickettsia prowazeki by two basic methods of cell culture.

Authors:  C L Wisseman; A D Waddell; W T Walsh
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

6.  The mechanism of interferon induction by UV-irradiated reovirus.

Authors:  D R Henderson; W K Joklik
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

7.  Production and properties of immune interferon from spleen cell cultures of Toxoplasma-infected mice.

Authors:  T Shirahata; K Shimizu
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

8.  Immune-type interferon-induced transfer of viral resistance.

Authors:  J E Blalock; J Georgiades; H M Johnson
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

9.  Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, Rickettsia akari.

Authors:  J Kazar; P A Krautwurst; F B Gordon
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

10.  Inhibition of the growth of Rickettsia prowazekii in cultured fibroblasts by lymphokines.

Authors:  J Turco; H H Winkler
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

View more
  20 in total

1.  Synthesis and secretion of interferon by murine fibroblasts in response to intracellular Listeria monocytogenes.

Authors:  E A Havell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Neutralization of lymphokine-mediated antirickettsial activity of fibroblasts and macrophages with monoclonal antibody specific for murine interferon gamma.

Authors:  T R Jerrells; J Turco; H H Winkler; G L Spitalny
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Establishment and characterization of a T-cell line specific for Rickettsia tsutsugamushi.

Authors:  K Kodama; S Kawamura; M Yasukawa; Y Kobayashi
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

4.  Gamma-interferon-induced inhibition of the growth of Rickettsia prowazekii in fibroblasts cannot be explained by the degradation of tryptophan or other amino acids.

Authors:  J Turco; H H Winkler
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

5.  Synthesis of DNA, rRNA, and protein by Rickettsia prowazekii growing in untreated or gamma interferon-treated mouse L929 cells.

Authors:  Q Gao; J Turco; H H Winkler
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

6.  Interferon-gamma inhibits growth of Coxiella burnetii in mouse fibroblasts.

Authors:  J Turco; H A Thompson; H H Winkler
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Gamma interferon production in response to homologous and heterologous strain antigens in mice chronically infected with Rickettsia tsutsugamushi.

Authors:  B A Palmer; F M Hetrick; T R Jerrells
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

8.  Effect of mouse lymphokines and cloned mouse interferon-gamma on the interaction of Rickettsia prowazekii with mouse macrophage-like RAW264.7 cells.

Authors:  J Turco; H H Winkler
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Role of the nitric oxide synthase pathway in inhibition of growth of interferon-sensitive and interferon-resistant Rickettsia prowazekii strains in L929 cells treated with tumor necrosis factor alpha and gamma interferon.

Authors:  J Turco; H H Winkler
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Effect of gamma interferon on phospholipid hydrolysis and fatty acid incorporation in L929 cells infected with Rickettsia prowazekii.

Authors:  H H Winkler; L Day; R Daugherty; J Turco
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.